Moreover, the co-administration of curcumin and 5-FU and oxaliplatin significantly suppressed EGFR signalling via the increased methylation status of EGFR, emphasizing the role of curcumin in the epigenetic modulation of colon cancer cells [89]. Here, EGFR is linked to colonic neoplasm.